The expression of cyclooxygenase and the production of prostaglandin E2 in neutrophils after burn injury and infection

Journal of Burn Care and Rehabilitation

Volumn 22, Issue 1, 2001, Pages 58-64

  He, L K ^a   Liu, L H ^a   Hahn, E ^a   Gamelli, R L ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINE; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; BURN INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; LEUKOCYTE ACTIVATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; SCALD; TIME;

EID: 0035138353     PISSN: 02738481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004630-200101000-00012     Document Type: Article

References (63)

1. The production of cytokines by polymorphonuclear neutrophils
2. Expression and activity of prostaglandin endoperoxide synthase-2 in agonistactivated human neutrophils
3. Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils
4. Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils
5. Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins
6. Neutrophil-mediated pulmonary vascular injury. Synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung
7. Current concepts: Immunology. Neutrophils in human diseases
8. Elastase in tissue injury
9. Tissue destruction by neutrophils
10. The role of the neutrophil in inflammatory diseases of the lung
11. Scientific perspectives on adult respiratory distress syndrome
12. Hypermetabolism, organ failure, and metabolic support
13. Multiple-organ failure. Generalized autodestructive inflammation?
14. Control of vascular permeability by polymorphonuclear leukocytes in inflammation
15. Distribution of COX-1 and COX-2 in normal and inflamed tissues
16. Identification of a phorbol ester-repressible v-src-inducible gene
17. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes
18. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide
19. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/ cyclooxygenase gene
20. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines
21. Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes
22. Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells
23. Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): Rationale for selective inhibition and progress to date
24. 2 elevated adenylate cyclase, and cyclic adenosine Monophosphate
25. Macrophage suppression of granulocyte and macrophage growth following burn wound infection
26. Cyclooxygenase-2 inhibitor NS-398 improves survival and restores leukocyte counts in burn infection
27. The release of leukotriene B4 during experimental inflammation
28. Prostaglandin release from human polymorphonuclear leukocytes
29. Thromboxane generation by human peripheral blood polymorphonuclear leukocytes
30. Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils
31. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts
32. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction
33. Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids
34. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids
35. Expression of inducible cyclooxygenase mRNA in the mouse brain after systemic administration of bacterial lipopolysaccharide
36. Inducible cyclooxygenase may have antiinflammatory properties
37. Tumor necrosis factor mediation of NSAID-induced gastric damage: Role of leukocyte adherence
38. Tumor necrosis factor-induced mortality is reversed with cyclooxygenase inhibition
39. 2 inhibition of acute changes in vascular permeability
40. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell
41. 2
42. 2
43. 2, and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels
44. Prostaglandins modulate macrophage Ia expression
45. Regulation of the immune response by prostaglandins
46. 2 may reside downstream of the PKC-dependent pathway
47. 2 and selective EP agonists on chemotaxis of human neutrophils
48. 2 on rat neutrophil aggregation
49. 2) and of thymic factor (TFX-thymomdlin) on bactericidal activity of human neutrophils
50. 2 inhibition of acute change in vascular permeability
51. 2
52. In vivo effects of interferon-gamma and indomethacin on murine alveolar macrophage activity
53. 2 by macrophages isolated after thermal injury and bacterial translocation
54. Neutrophil migration during endotoxemia
55. An aberration in the kinetics and control of TNF production by macrophages after thermal injury
56. 2 production by trauma patients' monocytes
57. Blockade of prostaglandin products augments macrophage and neutrophil tumor necrosis factor synthesis in burn injury
58. 2 production by lipopolysaccharide-stimulated monocytes
59. Inducible cyclooxygenase may have anti-inflammatory properties
60. Mediators of microvascular injury in dermal burn wounds